Schedule 13G ownership disclosure

BIOXCEL THERAPEUTICS INC

Security class unavailable · CUSIP: 09075P105

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,180,000
Percent of class
45.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-061005
Form type
SC 13G/A
Filer
BioXcel LLC
CIK
CIK 1651990
Filed
May 14, 2020
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub